Pictet North America Advisors Sa Teva Pharmaceutical Industries LTD Transaction History

Pictet North America Advisors Sa

$1.01 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$8.36 - $11.37 $383,097 - $521,030	-45,825 Reduced 57.5%	33,864 $300 Million
Q4 2022 Mar 22, 2023	SELL	$7.95 - $9.48 $6.72 Million - $8.02 Million	-845,718 Reduced 91.39%	79,689 $727 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $39,959 - $69,608	-5,825 Reduced 0.63%	925,407 $7.47 Billion
Q2 2022 Aug 05, 2022	SELL	$7.38 - $10.4 $248,543 - $350,251	-33,678 Reduced 3.49%	931,232 $7 Million
Q1 2022 May 06, 2022	SELL	$7.33 - $9.39 $60,237 - $77,167	-8,218 Reduced 0.84%	964,910 $9.06 Million
Q4 2021 Feb 04, 2022	SELL	$7.9 - $10.19 $55,908 - $72,114	-7,077 Reduced 0.72%	973,128 $7.8 Million
Q3 2021 Nov 10, 2021	SELL	$8.38 - $10.18 $58,299 - $70,822	-6,957 Reduced 0.7%	980,205 $9.64 Million
Q2 2021 Aug 11, 2021	BUY	$9.9 - $11.56 $125,660 - $146,731	12,693 Added 1.3%	987,162 $9.83 Million
Q1 2021 May 10, 2021	BUY	$10.34 - $12.81 $9.05 Million - $11.2 Million	875,006 Added 879.73%	974,469 $11.1 Million
Q4 2020 Feb 10, 2021	BUY	$8.61 - $11.04 $342,402 - $439,038	39,768 Added 66.62%	99,463 $946,000
Q3 2020 Nov 10, 2020	SELL	$8.57 - $12.69 $57,847 - $85,657	-6,750 Reduced 10.16%	59,695 $541,000
Q1 2020 Apr 30, 2020	BUY	$6.69 - $13.45 $444,517 - $893,685	66,445 New	66,445 $612,000
Q2 2019 Aug 07, 2019	SELL	$8.12 - $15.72 $495,271 - $958,825	-60,994 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$15.58 - $20.01 $41,302 - $53,046	-2,651 Reduced 4.17%	60,994 $950,000
Q4 2018 Jan 31, 2019	SELL	$14.59 - $23.84 $674,524 - $1.1 Million	-46,232 Reduced 42.08%	63,645 $999,000
Q3 2018 Nov 07, 2018	BUY	$21.06 - $25.65 $85,271 - $103,856	4,049 Added 3.83%	109,877 $2.41 Million
Q2 2018 Aug 10, 2018	BUY	$16.77 - $24.71 $206,908 - $304,871	12,338 Added 13.2%	105,828 $2.51 Million
Q1 2018 May 08, 2018	BUY	$16.68 - $22.07 $1.56 Million - $2.06 Million	93,490 New	93,490 $1.59 Million
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $1.18 Million - $2.01 Million	-105,149 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$15.41 - $32.17 $1.62 Million - $3.38 Million	105,149	105,149 $1.84 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$734 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$619 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$590 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$493 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$453 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet North America Advisors Sa with notifications on news.

Account